Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00322374 | Phase I Combination w/ Epirubicin | completed | Phase 1 | 42 | R-PharmINDUSTRY | 2 | Mar 10, 2016 | clinicaltrials |
| NCT00568022 | A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer | completed | Phase 1 | 9 | R-PharmINDUSTRY | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00508586 |
| PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer |
| completed |
| Phase 1 |
| 33 |
| PTC TherapeuticsINDUSTRY |
| 1 |
| Mar 3, 2016 |
| clinicaltrials |
| NCT02523417 | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer | completed | Phase 1 / Phase 2 | 15 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT00247013 | Automated Tele Counseling for Screening Mammography | completed | Phase 1 | 2,120 | Boston Medical CenterOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT00933309 | The Impact of Obesity and Obesity Treatments on Breast Cancer | completed | Phase 1 | 25 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 19, 2016 | clinicaltrials |
| NCT00027807 | Biological Therapy in Treating Women With Stage IV Breast Cancer | completed | Phase 1 | 6 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT00753207 | Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 | completed | Phase 1 | 10 | Cancer Trials IrelandNETWORK | 1 | Feb 15, 2016 | clinicaltrials |
| NCT01202591 | Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients(GLOW) | completed | Phase 1 / Phase 2 | 127 | AstraZenecaINDUSTRY | 8 | Feb 11, 2016 | clinicaltrials |
| NCT02020291 | Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer | completed | Phase 1 | 31 | WntResearch ABINDUSTRY | 1 | Feb 2, 2016 | clinicaltrials |
| NCT01018108 | Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer Survivors | completed | Phase 1 | 7 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT00468585 | Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model | completed | Phase 1 / Phase 2 | 62 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 22, 2016 | clinicaltrials |
| NCT00900627 | Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)(THYME) | completed | Phase 1 / Phase 2 | 330 | AstraZenecaINDUSTRY | 14 | Jan 20, 2016 | clinicaltrials |
| NCT01502592 | Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer | completed | Phase 1 | 19 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT00426556 | Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer | completed | Phase 1 | 88 | Novartis PharmaceuticalsINDUSTRY | 5 | Dec 28, 2015 | clinicaltrials |
| NCT00574977 | Safety Study of Modified Vaccinia Virus to Cancer | completed | Phase 1 | 26 | David BartlettOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00581815 | Spectroscopy With Surface Coils and Decoupling | completed | Phase 1 | 582 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00605397 | PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer(Cu-64 HER2+) | completed | Phase 1 | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 28, 2015 | clinicaltrials |
| NCT00039286 | Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer | completed | Phase 1 | 118 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00109785 | PET Scans in Patients With Locally Advanced Breast Cancer | completed | Phase 1 | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00582920 | Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer | completed | Phase 1 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00588003 | Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer | completed | Phase 1 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT00732056 | A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer | completed | Phase 1 | 24 | Geron CorporationINDUSTRY | 1 | Dec 24, 2015 | clinicaltrials |
| NCT01095848 | A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer | completed | Phase 1 | 23 | ImmunoVaccine Technologies, Inc. (IMV Inc.)INDUSTRY | 1 | Dec 15, 2015 | clinicaltrials |
| NCT00968409 | Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)(FFNP) | completed | Phase 1 | 20 | Washington University School of MedicineOTHER | 1 | Dec 9, 2015 | clinicaltrials |
| NCT01626066 | Cathepsin Activatable Fluorescent Probe(LUM015) | completed | Phase 1 | 15 | David KirschOTHER | 1 | Dec 9, 2015 | clinicaltrials |
| NCT01815294 | A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer | completed | Phase 1 | 54 | Janssen Research & Development, LLCINDUSTRY | 4 | Dec 4, 2015 | clinicaltrials |
| NCT01172028 | Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | University of ArizonaOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT00571987 | Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Decrease Re-operation(eRFA) | completed | Phase 1 / Phase 2 | 107 | University of ArkansasOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT00368875 | Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 54 | National Cancer Institute (NCI)NIH | 1 | Nov 5, 2015 | clinicaltrials |
| NCT00773344 | Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin | completed | Phase 1 / Phase 2 | 25 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 4, 2015 | clinicaltrials |
| NCT01265927 | A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer | completed | Phase 1 | 10 | Indiana UniversityOTHER | 1 | Oct 27, 2015 | clinicaltrials |
| NCT00276536 | Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma(IFNa) | completed | Phase 1 | 35 | The Cleveland ClinicOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00095706 | Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF) | completed | Phase 1 / Phase 2 | 50 | Translational Oncology Research InternationalOTHER | 1 | Sep 25, 2015 | clinicaltrials |
| NCT02338804 | Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma Patient | completed | Phase 1 / Phase 2 | 20 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 10, 2015 | clinicaltrials |
| NCT00932373 | A Study of Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer Who Have Previously Received a Trastuzumab-Containing Regimen | completed | Phase 1 | 54 | Genentech, Inc.INDUSTRY | 0 | Aug 26, 2015 | clinicaltrials |
| NCT02437539 | Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography(uPAR-PET) | completed | Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Aug 24, 2015 | clinicaltrials |
| NCT00425776 | Treatment of Hot Flushes in Breast Cancer Patients With Acupuncture | completed | Phase 1 | 94 | Vejle HospitalOTHER | 1 | Aug 21, 2015 | clinicaltrials |
| NCT00978913 | Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma | completed | Phase 1 | 31 | Inge Marie SvaneOTHER | 1 | Aug 19, 2015 | clinicaltrials |
| NCT00327288 | Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients | completed | Phase 1 | 34 | AmpliMed CorporationINDUSTRY | 1 | Jun 24, 2015 | clinicaltrials |
| NCT00100893 | IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer | completed | Phase 1 | 37 | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00632489 | LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients | completed | Phase 1 | 20 | SCRI Development Innovations, LLCOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00709020 | White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors | completed | Phase 1 | 16 | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01281150 | Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | May 25, 2015 | clinicaltrials |
| NCT00721565 | An Exercise Intervention for Breast Cancer Patients: Feasibility and Effectiveness (BEAT Cancer Trial; Pilot Study)(BEAT) | completed | Phase 1 | 49 | University of Alabama at BirminghamOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00070252 | Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer | completed | Phase 1 / Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | May 4, 2015 | clinicaltrials |
| NCT00020410 | Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00019435 | LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00301730 | Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung | completed | Phase 1 | 1 | National Cancer Institute (NCI)NIH | 1 | Apr 28, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Mar 10, 2016source: clinicaltrials